Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis

The efficacy of trovafloxacin against Staphylococcus aureus and viridans group streptococci was investigated in vitro and in an experimental model of endocarditis. The MICs at which trovafloxacin and ciprofloxacin inhibited 90% of clinical isolates of such bacteria (MIC(90)s) were (i) 0.03 and 2 mg/...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Entenza, J. M., Vouillamoz, J., Glauser, M. P., Moreillon, P.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1999
Teme:	Experimental Therapeutics
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89024/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9869569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.1.77
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!